|
Access the live webcast and webcast archive for Q1 2008 Par Pharmaceutical Companies, Inc. Earnings Conference Call on Friday, May 9, 2008 at 8:00 AM ET. Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned subsidiary, Par Pharmaceutical, Inc., is in the business of developing, manufacturing and distributing generic and branded drugs in the United States. The Company is divided into two business segments: generic pharmaceuticals and brand pharmaceuticals. Under generic segment, Par Pharmaceutical markets generic prescription drugs consisting of approximately 180 products representing various dosage strengths for approximately 80 separate drugs. In the brand segment, Par Pharmaceutical markets trademarked brand names designed to create an association between the products and their intended uses.
|
